XML 21 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
12 Months Ended
Apr. 01, 2023
Apr. 02, 2022
Mar. 27, 2021
Cash flows from operating activities:      
Net income (loss) $ 522.7 $ 600.1 $ (121.1)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:      
Depreciation and amortization expense 220.5 229.7 247.6
Deferred income tax expense (benefit) 3.9 (46.1) 35.6
Stock-based compensation expense 75.5 81.7 72.7
Impairment of assets 9.7 21.3 96.0
Bad debt expense (reversal) 2.3 (2.2) (27.6)
Other non-cash charges 1.0 1.0 1.8
Changes in operating assets and liabilities:      
Accounts receivable (52.6) 32.4 (143.0)
Inventories (106.2) (269.3) 3.7
Prepaid expenses and other current assets (19.9) (28.3) 5.2
Accounts payable and accrued liabilities (225.0) 194.6 293.6
Income tax receivables and payables 5.7 (62.3) (37.8)
Operating lease ROU asset and liabilities, net (17.5) (61.6) (30.2)
Other balance sheet changes (9.1) 24.9 (15.6)
Net cash provided by operating activities 411.0 715.9 380.9
Cash flows from investing activities:      
Capital expenditures (217.5) (166.9) (107.8)
Purchases of investments (598.6) (1,510.6) (704.6)
Proceeds from sales and maturities of investments 1,293.4 964.6 1,007.2
Settlement of net investment hedges 0.0 0.0 3.7
Other investing activities (5.8) (5.0) (3.5)
Net cash provided by (used in) investing activities 471.5 (717.9) 195.0
Cash flows from financing activities:      
Repayments of credit facility borrowings 0.0 0.0 (475.0)
Proceeds from the issuance of long-term debt 0.0 0.0 1,241.9
Repayments of long-term debt (500.0) 0.0 (300.0)
Payments of finance lease obligations (21.9) (23.1) (13.9)
Payments of dividends (198.3) (150.0) (49.8)
Repurchases of common stock, including shares surrendered for tax withholdings (488.6) (492.6) (37.7)
Other financing activities 0.0 0.0 (8.7)
Net cash provided by (used in) financing activities (1,208.8) (665.7) 356.8
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (8.8) (48.3) 25.5
Net increase (decrease) in cash, cash equivalents, and restricted cash (335.1) (716.0) 958.2
Cash, cash equivalents, and restricted cash at beginning of period 1,872.0 2,588.0 1,629.8
Cash, cash equivalents, and restricted cash at end of period $ 1,536.9 $ 1,872.0 $ 2,588.0